A taurolidine-citrate-heparin lock solution effectively eradicates pathogens from the catheter biofilm in hemodialysis patients

American Journal of Therapeutics

Volumn 23, Issue 2, 2016, Pages e363-e368

  Zwiech, Rafał ^a,b   Adelt, Maria ^b   Chrul, Sławomir ^a,b  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b Norbert Barlicki Memorial Teaching Hospital ^*  (Poland)

Author keywords

biofilm colonization; catheter; eradication; hemodialysis; pathogens

Indexed keywords

CITRIC ACID; HEPARIN; TAUROLIDINE; SOLUTION AND SOLUBILITY; TAURINE; THIADIAZINE DERIVATIVE;

ADULT; ARTICLE; BACTEREMIA; BIOFILM; BLOOD CULTURE; CATHETER INFECTION; CHRONIC PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; DIALYSIS CATHETER; DRUG EFFICACY; END STAGE RENAL DISEASE; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; MALE; MIDDLE AGED; NONHUMAN; PATHOGEN CLEARANCE; PERIPHERAL VEIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STAPHYLOCOCCUS INFECTION; ADVERSE EFFECTS; AGED; ANALOGS AND DERIVATIVES; CATHETER-RELATED INFECTIONS; DRUG EFFECTS; SOLUTION AND SOLUBILITY;

ADULT; AGED; BACTEREMIA; BIOFILMS; CATHETER-RELATED INFECTIONS; CITRIC ACID; FEMALE; HEPARIN; HUMANS; MALE; MIDDLE AGED; RENAL DIALYSIS; SOLUTIONS; TAURINE; THIADIAZINES;

EID: 84877118384     PISSN: 10752765     EISSN: 15363686     Source Type: Journal    
DOI: 10.1097/MJT.0b013e31828d4610     Document Type: Article

References (22)

1. Beathard GA. Infection associated with tunneled hemodialysis catheters. Semin Dial. 2008; 21: 528-538
2. Raad I. Intravascular-catheter-related infections. Lancet. 1998; 351: 893-898
3. Dittmer ID, Sharp D, McNulty CAM, et al. A prospective study of central venous hemodialysis catheter colonisation and peripheral bacteremia. Clin Nephrol. 1998; 51: 34-39
4. Krishnasami Z, Carlton D, Bimbo L, et al. Management of hemodialysis catheter related bacteremia with an adjunctive antibiotic lock solution. Kidney Int. 2002; 61: 1136-1142
5. Filiopoulos V, Hadjiyannakos D, Koutis I, et al. Approaches to prolong the use of uncuffed hemodialysis catheters: results of a randomized trial. Am J Nephrol. 2011; 33: 260-268
6. Betjes MGH, van Agteren M. Prevention of dialysis catheterrelated sepsis with a citrate-taurolidine-containing lock solution. Nephrol Dial Transpl. 2004; 19: 1546-1551
7. Shah CB, Mittelman MW, Costerton JW, et al. Antimicrobial activity of a novel catheter lock solution. Antimicrob Agents Chemother. 2002; 46: 1674-1679
8. Allon M. Prophylaxis against dialysis catheter-related bacteremia with a novel antimicrobial lock solution. Clin Infect Dis. 2003; 36: 1539-1544
9. Kidney Disease Outcomes Quality Initiative Group. K/DOQI clinical practice guideline and practical recommendations for anemia in chronic kidney disease: update of hemoglobin target. Am J Kidney Dis. 2007; 50: 471-530
10. Kidney Disease Outcomes Quality Initiative Group. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease patients. Am J Kidney Dis. 2003; 42: S1-S202
11. Saad TF. Bacteremia associated with tunnelled-cuffed hemodialysis catheters. Am J Kidney Dis. 1999; 34: 1114-1124
12. Weijmer MC, Debets-Ossenkopp YJ, van de Vondervoort FJ, et al. Superior antimicrobial activity of trisodium citrate over heparin for catheter locking. Nephrol Dial Transpl. 2002; 17: 2189-2195
13. Dogra GK, Herson H, Hutchison B, et al. Prevention of tunnelled hemodialysis catheter-related infections using catheter-restricted filling with gentamycin and citrate: a randomised controlled study. J Am Soc Nephrol. 2002; 13: 2133-2139
14. Buturovic J, Ponikva R, Kandus A, et al. Hemodialysis catheters in the interdialytic period. Heparin versus citrate versus polygeline: a prospective randomised study. Int J Artif Organs. 1998; 22: 945-947
15. Solomon LR, Cheesbrough JS, Bhargava R, et al. Observational study of need for thrombolytic therapy and incidence of bacteremia using taurolidine-citrate-heparin, taurolidine- citrate and heparin catheter locks in patients treated with hemodialysis. Semin Dial. 2001; 25: 233-238
16. Diskin CJ, Stokes TJ, Dansby LM, et al. Is systemic heparin a risk factor for catheter-related sepsis in dialysis patients?. an evaluation of various biofilm and traditional risk factors. Nephron Clin Pract. 2007; 107: 128-132
17. Diskin CJ. Lessons from single cell organisms: insights into the antimicrobial and toxic effects of peritoneal dialysate bases. Ther Apher Dial. 2010; 14: 127-135
18. Shavit L, Lifschitz M, Plaksin J, et al. High dose urokinase for restoration of patency of occluded permanent central venous catheters in hemodialysis patients. Clin Nephrol. 2010; 74: 297-302
19. Shavit L, Lifschitz M, Plaksin J, et al. Urokinase for restoration of patency of occluded permanent central venous access in haemodialysis patients-A new protocol. Nephrol Dial Transpl. 2007; 22: 666-667
20. Teehan GS, Bahdouch D, Ruthazer R, et al. Iron storage indices: novel predictors of bacteremia in hemodialysis patients initiating intravenous iron therapy. Clin Infect Dis. 2004; 5: 1090-1094
21. Jean G. Incidence and risk factors for infections from hemodialysis catheters. Nephrologie. 2001; 22: 443-448
22. Gulati S, Sahu KM, Avula S, et al. Role of vascular access as a risk factor for infections in hemodialysis. Ren Fail. 2003; 25: 967-973